#USA #Anaheim #Ozelle #O-Cyte 1 #ADLM 2026

Ozelle Unveils O-Cyte 1 at ADLM 2026

Ozelle is set to make waves in the medical community with the debut of its latest creation, the O-Cyte 1, at the prestigious ADLM 2026 conference in Anaheim, California. This automated hematology analyzer combines advanced AI technology and efficient morphological analysis, marking a significant advancement in the realm of hematology.

The Future of Hematology at Your Fingertips

For decades, cellular morphology has been a cornerstone of insights in hematology. However, seamlessly integrating morphology into routine workflows has been a daunting challenge, especially without sacrificing productivity. Traditional microscopy relies heavily on expert knowledge, while digital approaches have struggled to fit into high-throughput settings effectively. O-Cyte 1 is designed to bridge this gap, capturing the intricacies of blood cell morphology in a high-throughput manner, ultimately enhancing lab efficiency.

What Sets O-Cyte 1 Apart?

Built on Ozelle's AI × CBM (Complete Blood Morphology) technology, O-Cyte 1 transforms cell images into structured morphological insights. This allows labs to go beyond mere numerical parameters and embrace image-based findings for a comprehensive interpretation. Its design prioritizes clinical productivity, enabling up to 60 tests per hour independently, with potential expansion capabilities reaching 360 tests per hour when further networked.

The compact, modular architecture of the O-Cyte 1 minimizes both operational complexity and maintenance needs, which is crucial for healthcare providers and lab operators aiming to boost output while maintaining high standards of care.

Raymond, the head of Ozelle's North America division, expressed enthusiasm about the product's potential: "O-Cyte 1 embodies our vision to make advanced morphological analyses practical, scalable, and accessible for everyday workflows in hematology. We are excited to showcase how AI-driven morphological analysis can be integrated into more productive hematology practices at ADLM."

Global Impact and Future Applications

The launch of O-Cyte 1 comes in response to the increased demand for efficient and scalable hematology solutions across North America, Europe, the Middle East, Southeast Asia, India, and beyond. Ozelle aims to empower various clinical environments with diagnostic systems designed for day-to-day practice, enhancing the overall quality of care.

During the ADLM 2026, attendees can visit Ozelle at booth 2517 to experience the O-Cyte 1 firsthand from July 28 to 30. For partners unable to attend in person, Ozelle invites them to request product briefings and explore regional collaboration opportunities.

As the world of hematology embraces AI-driven tools, O-Cyte 1 stands poised to transform blood analysis, creating efficiencies that once seemed unattainable. The fast-approaching future of hematology is not just about technology; it's about improving patient care and operational excellence, allowing labs to serve their communities with unprecedented speed and accuracy.

For more information, interested parties can reach out to Ozelle through their website Ozelle Medical or contact them directly via email.